Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Leboucher

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Presse Medicale (Paris, France : 1983)|October 31, 2002
[Risks related to cytostatic exposure for nursing staff]Gilles Leboucher
Mycoses|May 12, 2019
Comparison of fks gene mutations and minimum inhibitory concentrations for the detection of Candida glabrata resistance to micafungin: A systematic review and meta-analysisAnne-Lise Bienvenu, Gilles Leboucher, Stephane Picot
Recherche En Soins Infirmiers|June 20, 2022
Bruno Charpiat, Gilles Leboucher, Pascal Maire, et al.
BMJ Case Reports|September 9, 2020
Septic shock due to refractory severe clostridioides difficile colitis rapidly resolving after faecal microbiota transplantationNicolas Benech, Gilles Leboucher, Céline Monard, et al.
Clinical Pharmacokinetics|May 28, 2014
Consequences of renal failure on non-renal clearance of drugsLaure Lalande, Bruno Charpiat, Gilles Leboucher, et al.
Recherche En Soins Infirmiers|September 29, 2020
[Injectable concentrated potassium concentrate, emblematic of the lack of safety of the drug use process in French hospitals]Bruno Charpiat, Gilles Leboucher, Pascal Maire, et al.
Retina (Philadelphia, Pa.)|March 12, 2011
"High-molecular-weight aggregates in repackaged bevacizumab"Bruno Charpiat, Emilie Dussossoy, Gilles Leboucher, et al.
One Health (Amsterdam, Netherlands)|December 27, 2021
Drug resistant parasites and fungi from a one-health perspective: A global concern that needs transdisciplinary stewardship programsStephane Picot, Frederic Beugnet, Gilles Leboucher, et al.
Bulletin Du Cancer|December 24, 2002
[Evaluation of platinum contamination of a hazardous drug preparation area in a hospital pharmacy]Gilles Leboucher, François Serratrice, Valérie Bertholle, et al.
Critical Care (London, England)|September 30, 2020
No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients-think empirical treatmentAnne-Lise Bienvenu, Nathalie Bleyzac, Jean-Christophe Richard, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Presse Medicale (Paris, France : 1983)|October 31, 2002
[Risks related to cytostatic exposure for nursing staff]Gilles Leboucher
Mycoses|May 12, 2019
Comparison of fks gene mutations and minimum inhibitory concentrations for the detection of Candida glabrata resistance to micafungin: A systematic review and meta-analysisAnne-Lise Bienvenu, Gilles Leboucher, Stephane Picot
Recherche En Soins Infirmiers|June 20, 2022
Bruno Charpiat, Gilles Leboucher, Pascal Maire, et al.
BMJ Case Reports|September 9, 2020
Septic shock due to refractory severe clostridioides difficile colitis rapidly resolving after faecal microbiota transplantationNicolas Benech, Gilles Leboucher, Céline Monard, et al.
Clinical Pharmacokinetics|May 28, 2014
Consequences of renal failure on non-renal clearance of drugsLaure Lalande, Bruno Charpiat, Gilles Leboucher, et al.
Recherche En Soins Infirmiers|September 29, 2020
[Injectable concentrated potassium concentrate, emblematic of the lack of safety of the drug use process in French hospitals]Bruno Charpiat, Gilles Leboucher, Pascal Maire, et al.
Retina (Philadelphia, Pa.)|March 12, 2011
"High-molecular-weight aggregates in repackaged bevacizumab"Bruno Charpiat, Emilie Dussossoy, Gilles Leboucher, et al.
One Health (Amsterdam, Netherlands)|December 27, 2021
Drug resistant parasites and fungi from a one-health perspective: A global concern that needs transdisciplinary stewardship programsStephane Picot, Frederic Beugnet, Gilles Leboucher, et al.
Bulletin Du Cancer|December 24, 2002
[Evaluation of platinum contamination of a hazardous drug preparation area in a hospital pharmacy]Gilles Leboucher, François Serratrice, Valérie Bertholle, et al.
Critical Care (London, England)|September 30, 2020
No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients-think empirical treatmentAnne-Lise Bienvenu, Nathalie Bleyzac, Jean-Christophe Richard, et al.
Pageof 4